Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03221387 · ClinicalTrials.gov registry record · NA
Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03221387 is a NA study that has completed, run by Temple University. The registered enrollment target is 30 participants.
The verdict
NCT03221387, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Humidified Nasal High-flow with Oxygen (HNHF-O2) therapy has been reported to have acute beneficial effects in patients with hypoxemic respiratory failure who have been hospitalized. The usefulness of this therapy in the outpatient setting is unproven. This pilot study will test the feasibility of using this therapy in the outpatient setting and its effects on sleep.
Interventions
- DEVICE Humidified nasal high flow with oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-09-10 |
| Est. Completion | 2019-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03221387
The ClinicalTrials.gov registry entry for NCT03221387 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Humidified nasal high flow with oxygen is the first listed.
NCT03221387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03221387 about?
NCT03221387 is a clinical study titled "Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients". Humidified Nasal High-flow with Oxygen (HNHF-O2) therapy has been reported to have acute beneficial effects in patients with hypoxemic respiratory failure who have been hospitalized. The usefulness of this therapy in the outpatient setting is unproven. This pilot study will test the feasibility of u...
What is the current status of trial NCT03221387?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-09-10. Estimated completion is 2019-12-15.
What interventions are being tested in trial NCT03221387?
The interventions under investigation include: Humidified nasal high flow with oxygen (DEVICE).
Who is sponsoring clinical trial NCT03221387?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.